+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Italy Diabetes Market Report: 2026-2034- Product Image
Italy Diabetes Market Report: 2026-2034- Product Image
New

Italy Diabetes Market Report: 2026-2034

  • PDF Icon

    Report

  • 136 Pages
  • April 2026
  • Region: Italy
  • IMARC Group
  • ID: 5985321
Description Jump to:
The Italy diabetes market size reached USD 1.16 billion in 2025. The analyst expects the market to reach USD 1.59 billion by 2034, exhibiting a growth rate (CAGR) of 3.44% during 2026-2034.

This new report “Italy Diabetes Market Report: 2026-2034” provides an analytical and statistical insight into the Italy diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Italy. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Italy diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Italy diabetes market in any form.

What this Report Achieves:

Comprehensive situation analysis of the Italy diabetes epidemiology and its dynamics:

Focus of the Analysis:

Historical, current and future prevalence of diabetes in Italy

Historical, current and future prevalence of type-1 and type-2 diabetes in Italy

Historical, current and future prevalence of diabetes in the urban and rural regions in Italy

Historical, current and future prevalence of diabetes among males and females in Italy

Historical, current and future prevalence of diabetes among various age groups in Italy

Historical, current and future diagnosis rates for diabetes in Italy

Historical, current and future drug treatment rates for diabetes in Italy

Comprehensive situation analysis of the Italy Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

Performance of the Oral Antidiabetics market in Italy

Performance of key classes

Performance of key players

Market outlook

Comprehensive situation analysis of the Italy Insulin market and its dynamics:

Focus of the Analysis:

Performance of the Insulin market in Italy

Performance of key classes

Performance of key players

Market outlook

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 Italy Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 Italy Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Forecast
7.5 SWOT Analysis
7.5.1 Overview
7.5.2 Strengths
7.5.3 Weaknesses
7.5.4 Opportunities
7.5.5 Threats
7.6 Value Chain Analysis
7.7 Porter’s Five Forces Analysis
7.7.1 Overview
7.7.2 Bargaining Power of Buyers
7.7.3 Bargaining Power of Suppliers
7.7.4 Degree of Competition
7.7.5 Threat of New Entrants
7.7.6 Threat of Substitutes
7.8 Market Breakup by Segment
7.8.1 Italy Oral Antidiabetics Market
7.8.1.1 Historical Market Trends
7.8.1.2 Market Breakup by Class
7.8.1.3 Market Shares of Key Players
7.8.1.4 Market Forecast
7.8.2 Italy Insulin Market
7.8.2.1 Historical Market Trends
7.8.2.2 Market Breakup by Class
7.8.2.3 Market Shares of Key Players
7.8.2.4 Market Forecast
8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players
List of Figures
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2025 & 2034
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Italy: Total Number of Diabetes Patients (in 000), 2020-2025
Figure 6: Italy: Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 7: Italy (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2020-2025
Figure 8: Italy (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 9: Italy (Urban & Rural): Total Number of Diabetes Patients (in 000), 2020-2025
Figure 10: Italy (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 11: Italy (Male & Female): Total Number of Diabetes Patients (in 000), 2020-2025
Figure 12: Italy (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 13: Italy: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2020-2025
Figure 14: Italy: Total Number of Diabetes Forecast Patients by Age Group (20-39, 40-59, 60-79, in 000), 2026-2034
Figure 15: Italy: Diabetes Drug Industry Overview
Figure 16: Italy: Diabetes Drug Market: Sales Value (in Million USD), 2020-2025
Figure 17: Italy: Diabetes Drug Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 18: Italy: Diabetes Drug Market: SWOT Analysis
Figure 19: Italy: Diabetes Drug Market: Value Chain Analysis
Figure 20: Italy: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Italy: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2020-2025
Figure 22: Italy: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2026-2034
Figure 23: Italy: Oral Antidiabetics Market: Sales Value (in Million USD), 2020-2025
Figure 24: Italy: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2020 & 2025
Figure 25: Italy: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Italy: Oral Antidiabetics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Italy: Insulin Market: Sales Value (in Million USD), 2020-2025
Figure 28: Italy: Breakup of Insulin Market by Class (in %), 2020 & 2025
Figure 29: Italy: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Italy: Insulin Market Forecast: Sales Value (in Million USD), 2026-2034
List of Tables
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2025 & 2034
Table 3: Italy: Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 4: Italy (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 5: Italy (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 6: Italy (Male & Female): Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 7: Italy: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2020, 2025 & 2034
Table 8: Italy: Diabetes Drug Market: Competitive Structure

Related Topics

Related Reports

France Diabetes Market Size, Share, Trends and Forecast by Product Type, 2026-2034 - Product Image

France Diabetes Market Size, Share, Trends and Forecast by Product Type, 2026-2034

  • Report
  • 136 Pages
  • France
From
Gestational Diabetes - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Gestational Diabetes - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Type 1 Diabetes Market Report and Forecast 2025-2034 - Product Image

Type 1 Diabetes Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Type 2 Diabetes Market Report 2026 - Product Image

Type 2 Diabetes Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Image

Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From

About the Antidiabetic Market

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.